Pharmacovigilance in the Community: A Special-Interest Group of the International Society of Pharmacovigilance

Résumé fourni par la source

Pharmacovigilance (PV) continues to evolve globally and has changed in the last few decades from depending on a reactive approach based on spontaneous reporting of adverse drug reactions (ADRs) to a more proactive and patient-centred approach [ 1 ]. To keep pace with these developments, PV stakeholders should adopt a multidisciplinary framework to release the untapped potential of their PV allies in the community [ 2 ].

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.